5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19237500 | IMPROVED MIRDAMETINIB TREATMENT | BRAUN, MADELINE E | 1624 | Final Rejection | Jun 13, 2025 |
| 19237417 | IMPROVED MIRDAMETINIB TREATMENT | SIMMONS, CHRIS E | 1622 | Non-Final OA | Jun 13, 2025 |
| 18185225 | TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA WITH MIRDAMETINIB | NOTTINGHAM, KYLE GREGORY | 1621 | Final Rejection | Mar 16, 2023 |
| 17906089 | A COMBINATION THERAPY WITH NIROGACESTAT AND A BCMA-DIRECTED THERAPY AND USES THEREOF | HEITMEIER, KENDALL NICOLE | 1621 | Final Rejection | Sep 12, 2022 |
| 17758913 | COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND GAMMA SECRETASE INHIBITORS | WEIDNER, ADAM M | 1675 | Final Rejection | Jul 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial